Medicare Enrolled
Dr. Addie Hill, M.D.
Hematology & Oncology · Athens, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hill?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hill
Dr. Addie Hill is a hematology & oncology specialist in Athens, GA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Hill performed 27,944 Medicare services across 2,921 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hill received a total of $5,592 from 48 pharmaceutical and/or device companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hill is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 14% volume in GA
$5,592 industry payments
Medicare Practice Summary
Medicare Utilization ↗27,944
Medicare services
Top 14% in GA for hematology & oncology
2,921
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,329 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
8,670 | $0 | $4 |
| Romosozumab injection (Evenity) for osteoporosis | 8,295 | $8 | $30 |
| Denosumab injection (Prolia/Xgeva) | 1,680 | $18 | $74 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,243 | $0 | $3 |
| Iron infusion (Monoferric) | 1,200 | $15 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
789 | $88 | $418 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
750 | $6 | $42 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
642 | $8 | $38 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
624 | $8 | $12 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
348 | $4 | $22 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
347 | $6 | $30 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
343 | $10 | $66 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
276 | $16 | $139 |
| Anti-nausea injection (ondansetron/Zofran) | 272 | $0 | $1 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
219 | $20 | $237 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
195 | $10 | $78 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
187 | $87 | $589 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
87 | $9 | $40 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
84 | $2 | $9 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
78 | $13 | $48 |
| Iron level test | 78 | $6 | $28 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
78 | $9 | $38 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
65 | $43 | $254 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
64 | $1 | $2 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
62 | $151 | $1,123 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
60 | $75 | $745 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
59 | $61 | $283 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
58 | $10 | $68 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
58 | $1 | $5 |
| Nephelometry test A laboratory test that uses light scattering to measure the concentration of specific substances in a sample. |
56 | $13 | $48 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
55 | $15 | $74 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
55 | $43 | $289 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
52 | $14 | $64 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
52 | $4 | $17 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
51 | $13 | $48 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $100 | $562 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
50 | $16 | $73 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
47 | $1 | $7 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
46 | $8 | $48 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
44 | $22 | $152 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
44 | $123 | $495 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
42 | $9 | $39 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
42 | $0 | $2 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
40 | $16 | $57 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $57 | $253 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
32 | $7 | $29 |
| New patient office visit, complex (60-74 min) | 32 | $150 | $709 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
27 | $49 | $298 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $94 | $476 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
21 | $14 | $73 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
20 | $86 | $386 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 20 | $310 | $2,115 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
19 | $86 | $363 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
18 | $25 | $151 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
18 | $19 | $106 |
| PSA test (prostate cancer screening) | 14 | $18 | $79 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $126 | $706 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
12 | $49 | $245 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
37.9% high complexity
45.8% medium
16.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,592
Total received (2018-2024)
Avg $799/year across 7 years
Top 42% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
181
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,069 (54.9%)
Other
Charitable contributions, space rental, and other categories
$2,426 (43.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$97 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,936
2023
$1,244
2022
$796
2021
$721
2020
$360
2019
$228
2018
$308
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,070
ABBVIE INC.
$112
Gilead Sciences, Inc.
$106
Daiichi Sankyo Inc.
$75
Janssen Biotech, Inc.
$59
Stemline Therapeutics Inc.
$52
Merck Sharp & Dohme LLC
$48
GENZYME CORPORATION
$47
PFIZER INC.
$44
Exelixis Inc.
$41
SOBI, INC
$40
Celgene Corporation
$34
Genmab U.S., Inc.
$32
Adaptive Biotechnologies Corporation
$29
Astellas Pharma US Inc
$24
Alexion Pharmaceuticals, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$20
Geron Corporation
$19
PharmaEssentia USA Corporation
$17
Regeneron Healthcare Solutions, Inc.
$17
GlaxoSmithKline, LLC.
$15
Mirati Therapeutics, Inc.
$15
Top 3 companies account for 66.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,227
AstraZeneca Pharmaceuticals LP
$282
NOVARTIS PHARMACEUTICALS CORPORATION
$266
E.R. Squibb & Sons, L.L.C.
$226
Janssen Biotech, Inc.
$194
ABBVIE INC.
$185
Daiichi Sankyo Inc.
$178
Stemline Therapeutics Inc.
$143
Amgen Inc.
$141
PFIZER INC.
$140
Gilead Sciences, Inc.
$126
Merck Sharp & Dohme LLC
$116
GlaxoSmithKline, LLC.
$100
Seagen Inc.
$89
Adaptive Biotechnologies Corporation
$86
GENZYME CORPORATION
$65
Eisai Inc.
$62
Celgene Corporation
$59
Seattle Genetics, Inc.
$57
Exelixis Inc.
$55
Rigel Pharmaceuticals, Inc.
$53
Alexion Pharmaceuticals, Inc.
$51
Sumitomo Pharma America, Inc.
$45
Regeneron Healthcare Solutions, Inc.
$43
Incyte Corporation
$40
SOBI, INC
$40
Genentech USA, Inc.
$39
Merck Sharp & Dohme Corporation
$38
Takeda Pharmaceuticals U.S.A., Inc.
$37
SERVIER PHARMACEUTICALS LLC
$32
Genmab U.S., Inc.
$32
Alnylam Pharmaceuticals Inc.
$29
Kite Pharma, Inc.
$28
Astellas Pharma US Inc
$24
TAIHO ONCOLOGY, INC.
$24
PUMA BIOTECHNOLOGY, INC.
$24
Taiho Oncology, Inc.
$22
Puma Biotechnology, Inc.
$22
RECORDATI_RARE_DISEASES_INC.
$20
Geron Corporation
$19
EMD Serono, Inc.
$19
Deciphera Pharmaceuticals Inc.
$18
ARRAY BIOPHARMA INC
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
PharmaEssentia USA Corporation
$17
Pharmacyclics LLC, an AbbVie Company
$16
Mirati Therapeutics, Inc.
$15
Blueprint Medicines Corporation
$12
Top 3 companies account for 49.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · BESREMI · BLENREP · BOSULIF · CABLIVI · CABOMETYX · CALQUENCE · DARZALEX · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · Enhertu · Epkinly · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INREBIC · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · NERLYNX · Nplate · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · Padcev · Perjeta · Phesgo · QINLOCK · REBLOZYL · RYTELO · Rezlidhia · SARCLISA · SCEMBLIX · SUTENT · SYLVANT · SYNAGIS · Stivarga · TALVEY · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · ULTOMIRIS · Ultomiris · VENCLEXTA · XTANDI · Yescarta · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (55%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
10
Per 100K population
12.4
County median income
$85,012
Nearest hospital
ST MARY'S HOSPITAL
5.4 mi
5.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hill is a mixed practice specialist, with above-average Medicare volume (top 14% in GA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hill experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Hill performed 8,670 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hill receive payments from pharmaceutical companies?
Yes. Dr. Hill received a total of $5,592 from 48 companies across 181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hill's costs compare to other hematology & oncology specialists in Athens?
Dr. Hill's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Athens
Browse hematology & oncology specialists in Athens ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
NOVARTIS PHARMACEUTICALS CORPORATION Payments to Doctors
See all physicians who received payments from NOVARTIS PHARMACEUTICALS CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology